- Home
- HRI vs KNSA Comparison
HRI vs KNSA Comparison
Compare HRI & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HRI | KNSA |
|---|---|---|
| Founded | 1965 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Misc Corporate Leasing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.9B |
| IPO Year | 2006 | 2018 |
Fundamental Metrics
Financial Performance| Metric | HRI | KNSA |
|---|---|---|
| Price | $165.16 | $78.92 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $162.33 | $60.86 |
| AVG Volume (30 Days) | 464.7K | ★ 667.7K |
| Earning Date | 04-28-2026 | 04-28-2026 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | N/A | ★ 225.00 |
| EPS | N/A | ★ 0.27 |
| Revenue | ★ $4,376,000,000.00 | $677,564,000.00 |
| Revenue This Year | $10.12 | $37.48 |
| Revenue Next Year | $6.16 | $17.87 |
| P/E Ratio | ★ N/A | $299.51 |
| Revenue Growth | 22.65 | ★ 60.09 |
| 52 Week Low | $88.45 | $32.89 |
| 52 Week High | $188.35 | $82.94 |
Technical Indicators
Market Signals| Indicator | HRI | KNSA |
|---|---|---|
| Relative Strength Index (RSI) | 54.27 | 65.10 |
| Support Level | $150.81 | $40.06 |
| Resistance Level | $172.56 | $82.94 |
| Average True Range (ATR) | 6.59 | 2.50 |
| MACD | -0.60 | -0.17 |
| Stochastic Oscillator | 62.79 | 82.45 |
Price Performance
Historical ComparisonAbout HRI Herc Holdings Inc.
Herc Holdings is an equipment rental company that was spun out of Hertz Global in 2016. It is currently the third-largest player in North America, after United Rentals and Sunbelt Rentals, with an approximate 6% market share pro forma for its 2025 acquisition of H&E Equipment Services. It serves a similar mix of companies to its peers (industrial, commercial, and residential construction) from its 450 locations targeting the top 100 metropolitan markets in the US. Herc's rental fleet of approximately $7 billion is also similar in composition to its peer group in terms of equipment offered. The company is also pursuing diversification by bundling and increasing specialty solutions for its customer base. Herc's portfolio skews toward local customers versus national accounts (60%/40%).
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.